Skip to main content
Top
Published in: Lung 6/2015

01-12-2015

Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes

Authors: Michal Shteinberg, Joseph Rivlin, Michal Gur, Muriel Konopnicki, Nili Stein, Michael M. Tunney, J. Stuart Elborn, Damian G. Downey, Elinor Johnston, Hadar Shalom, Andrew Levy

Published in: Lung | Issue 6/2015

Login to get access

Abstract

Haptoglobin (Hp), a heme-Iron chelator, has different isoforms which are associated with variable tendency toward infections: Hp 1-1, Hp 2-1, and Hp 2-2. Cystic fibrosis (CF) outcomes are variable and influenced by genetic and environmental factors. The aim of this study was to determine whether Hp phenotype influenced disease severity in CF. One hundred forty-two CF patients from two centers were analyzed for Haptoglobin phenotype using gel electrophoresis of hemoglobin enriched serum. Clinical and microbiological data including bacterial colonization status, lung function, presence of CF-related diabetes and liver disease, rate of exacerbation, and mortality were compared between Hp phenotype groups. We found a trend toward less mucoid PA among Hp 2-2 (20.4 %) compared with Hp 1-1 and Hp 2-1 individuals (33.3 %), p = 0.317. Hp 2-2 individuals also had less antibiotic courses, and lower inflammatory markers without statistical significance. Haptoglobin phenotype is unlikely to be an important modifier of CF phenotype.
Literature
1.
go back to reference Guillot L, Beucher J, Tabary O, Le Rouzic P, Clement A, Corvol H (2014) Lung disease modifier genes in cystic fibrosis. Int J Biochem Cell Biol 52:83–93CrossRefPubMed Guillot L, Beucher J, Tabary O, Le Rouzic P, Clement A, Corvol H (2014) Lung disease modifier genes in cystic fibrosis. Int J Biochem Cell Biol 52:83–93CrossRefPubMed
2.
go back to reference Mogayzel PJ, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B, Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B (2013) Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 187(7):680–689CrossRefPubMed Mogayzel PJ, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B, Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B (2013) Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 187(7):680–689CrossRefPubMed
3.
go back to reference Kim EJ, Sabra W, Zeng AP (2003) Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology 149(Pt 9):2627–2634CrossRefPubMed Kim EJ, Sabra W, Zeng AP (2003) Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology 149(Pt 9):2627–2634CrossRefPubMed
4.
go back to reference Berlutti F, Morea C, Battistoni A, Sarli S, Cipriani P, Superti F, Ammendolia MG, Valenti P (2005) Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 18(4):661–670PubMed Berlutti F, Morea C, Battistoni A, Sarli S, Cipriani P, Superti F, Ammendolia MG, Valenti P (2005) Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 18(4):661–670PubMed
5.
go back to reference Berlutti F, Superti F, Nicoletti M, Morea C, Frioni A, Ammendolia MG, Battistoni A, Valenti P (2008) Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 21(1):51–59PubMed Berlutti F, Superti F, Nicoletti M, Morea C, Frioni A, Ammendolia MG, Battistoni A, Valenti P (2008) Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 21(1):51–59PubMed
6.
go back to reference O’May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW (2009) Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 58(Pt 6):765–773CrossRefPubMed O’May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW (2009) Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 58(Pt 6):765–773CrossRefPubMed
7.
go back to reference Valenti P, Catizone A, Pantanella F, Frioni A, Natalizi T, Tendini M, Berlutti F (2011) Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm. Int J Immunopathol Pharmacol 24(4):1057–1068PubMed Valenti P, Catizone A, Pantanella F, Frioni A, Natalizi T, Tendini M, Berlutti F (2011) Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm. Int J Immunopathol Pharmacol 24(4):1057–1068PubMed
8.
go back to reference Vogel AR, Szelestey BR, Raffel FK, Sharpe SW, Gearinger RL, Justice SS, Mason KM (2012) SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus. Front Cell Infect Microbiol 2:42PubMedCentralCrossRefPubMed Vogel AR, Szelestey BR, Raffel FK, Sharpe SW, Gearinger RL, Justice SS, Mason KM (2012) SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus. Front Cell Infect Microbiol 2:42PubMedCentralCrossRefPubMed
9.
go back to reference Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O’Toole GA, Stanton BA (2008) The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Cell Mol Physiol 295(1):L25–L37CrossRef Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O’Toole GA, Stanton BA (2008) The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Cell Mol Physiol 295(1):L25–L37CrossRef
10.
go back to reference Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R (2010) Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 12(2):293–304CrossRefPubMed Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R (2010) Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 12(2):293–304CrossRefPubMed
11.
go back to reference Burbea Z, Nakhoul F, Zoabi R, Hochberg I, Levy NS, Benchetrit S, Weissgarten J, Tovbin D, Knecht A, Iaina A, Herman M, Kristal B, Levy AP (2004) Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients. Ann Clin Biochem 41(Pt 6):469–473CrossRefPubMed Burbea Z, Nakhoul F, Zoabi R, Hochberg I, Levy NS, Benchetrit S, Weissgarten J, Tovbin D, Knecht A, Iaina A, Herman M, Kristal B, Levy AP (2004) Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients. Ann Clin Biochem 41(Pt 6):469–473CrossRefPubMed
12.
go back to reference Wasserzug O, Blum S, Klement E, Lejbkowicz F, Miller-Lotan R, Levy AP (2007) Haptoglobin 1-1 genotype and the risk of life-threatening streptococcus infection: evolutionary implications. J Infect 54(4):410CrossRefPubMed Wasserzug O, Blum S, Klement E, Lejbkowicz F, Miller-Lotan R, Levy AP (2007) Haptoglobin 1-1 genotype and the risk of life-threatening streptococcus infection: evolutionary implications. J Infect 54(4):410CrossRefPubMed
13.
go back to reference Kasvosve I, Speeckaert MM, Speeckaert R, Masukume G, Delanghe JR (2010) Haptoglobin polymorphism and infection. Adv Clin Chem 50:23–46CrossRefPubMed Kasvosve I, Speeckaert MM, Speeckaert R, Masukume G, Delanghe JR (2010) Haptoglobin polymorphism and infection. Adv Clin Chem 50:23–46CrossRefPubMed
14.
go back to reference Kerem E, Kerem B (1996) Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 22(6):387–395CrossRefPubMed Kerem E, Kerem B (1996) Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 22(6):387–395CrossRefPubMed
15.
go back to reference Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42(10):1589–1600PubMed Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42(10):1589–1600PubMed
16.
go back to reference Chillappagari S, Venkatesan S, Garapati V, Mahavadi P, Munder A, Seubert A, Sarode G, Guenther A, Schmeck BT, Tummler B, Henke MO (2014) Impaired TLR4 and HIF expression in cystic fibrosis bronchial epithelial cells downregulates hemeoxygenase-1 and alters iron homeostasis in vitro. Am J Physiol Cell Mol Physiol 307(10):L791–L799CrossRef Chillappagari S, Venkatesan S, Garapati V, Mahavadi P, Munder A, Seubert A, Sarode G, Guenther A, Schmeck BT, Tummler B, Henke MO (2014) Impaired TLR4 and HIF expression in cystic fibrosis bronchial epithelial cells downregulates hemeoxygenase-1 and alters iron homeostasis in vitro. Am J Physiol Cell Mol Physiol 307(10):L791–L799CrossRef
17.
go back to reference Delanghe J, Langlois M, Ouyang J, Claeys G, De Buyzere M, Wuyts B (1998) Effect of haptoglobin phenotypes on growth of Streptococcus pyogenes. Clin Chem Lab Med 36(9):691–696CrossRefPubMed Delanghe J, Langlois M, Ouyang J, Claeys G, De Buyzere M, Wuyts B (1998) Effect of haptoglobin phenotypes on growth of Streptococcus pyogenes. Clin Chem Lab Med 36(9):691–696CrossRefPubMed
18.
go back to reference Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409(6817):198–201CrossRefPubMed Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409(6817):198–201CrossRefPubMed
19.
go back to reference McKone EF, Shao J, Frangolias DD, Keener CL, Shephard CA, Farin FM, Tonelli MR, Pare PD, Sandford AJ, Aitken ML (2006) Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease. Am J Respir Crit Care Med 174(4):415–419PubMedCentralCrossRefPubMed McKone EF, Shao J, Frangolias DD, Keener CL, Shephard CA, Farin FM, Tonelli MR, Pare PD, Sandford AJ, Aitken ML (2006) Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease. Am J Respir Crit Care Med 174(4):415–419PubMedCentralCrossRefPubMed
Metadata
Title
Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes
Authors
Michal Shteinberg
Joseph Rivlin
Michal Gur
Muriel Konopnicki
Nili Stein
Michael M. Tunney
J. Stuart Elborn
Damian G. Downey
Elinor Johnston
Hadar Shalom
Andrew Levy
Publication date
01-12-2015
Publisher
Springer US
Published in
Lung / Issue 6/2015
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-015-9801-z

Other articles of this Issue 6/2015

Lung 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.